NCT01943305
The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans Not Available 2 completed NCT02880865
Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) Vaccine prevention 4 completed NCT02514746
Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose No drug interventions prevention 4 completed NCT00621764
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children No drug interventions prevention 2 completed NCT00463684
Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age No drug interventions prevention 4 completed NCT01188343
Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers No drug interventions prevention 3 completed NCT01466387
A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults prevention 3 completed NCT00314145
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX No drug interventions prevention 3 completed NCT01190228
Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CV prevention 3 completed NCT00596271
Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440 No drug interventions prevention 3 completed NCT00595309
Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 No drug interventions prevention 3 completed NCT00605085
Safety and Tolerability of the Japanese Encephalitis Vaccine IC51 No drug interventions prevention 3 completed NCT02602652
Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine No drug interventions prevention Not Available completed NCT00595270
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51 No drug interventions prevention 3 completed NCT01150942
Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea No drug interventions prevention 3 completed NCT04817917
Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province prevention 4 unknown_status NCT00981630
Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine No drug interventions prevention 2 completed NCT02492165
Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy Subjects prevention 3 completed NCT01567865
Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine No drug interventions prevention 4 completed NCT06372665
Safety Observation of the Japanese Encephalitis Vaccine Given With a Primary Immunization No drug interventions Not Available Not Available recruiting NCT01559831
Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination Not Available 1 withdrawn NCT01815073
Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine prevention 4 completed NCT01386827
Ixiaro as Booster After Mouse-brain Derived Vaccines for Japanese Encephalitis prevention 3 completed NCT00463476
Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine No drug interventions prevention 4 completed NCT00319592
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAX No drug interventions prevention 2 completed NCT02532569
Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vaccineinj No drug interventions prevention 4 completed NCT01396512
Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in Toddlers No drug interventions prevention 3 completed NCT01954810
Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children No drug interventions prevention 4 unknown_status NCT00604708
Immunogenicity Study of the Japanese Encephalitis Vaccine IC51 No drug interventions prevention 3 completed NCT00595790
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51 No drug interventions prevention 3 completed NCT00596102
Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51 No drug interventions Not Available Not Available completed NCT06331702
Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR) No drug interventions prevention 4 recruiting NCT00938379
Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR No drug interventions prevention 3 unknown_status NCT01246479
Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study No drug interventions other 3 completed NCT02643433
Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines No drug interventions prevention 4 completed NCT02816554
Safety and Immunogenicity of JECEVAX in Young Children No drug interventions prevention 2 completed NCT05568953
An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity No drug interventions basic_science 2 recruiting NCT01856205
Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis No drug interventions treatment 2 completed NCT03920111
Flavivirus Cross-priming Potential of IMOJEV No drug interventions diagnostic Not Available completed NCT01001988
Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers No drug interventions prevention 3 completed NCT01092507
A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers No drug interventions prevention 3 completed NCT00982137
Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) No drug interventions prevention 2 completed NCT00314132
Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. No drug interventions prevention 3 completed NCT01656200
A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 No drug interventions basic_science 4 completed NCT00441259
Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age No drug interventions prevention 2 completed NCT00981175
A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults No drug interventions prevention 2 completed NCT03282370
Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam No drug interventions prevention 3 completed NCT01158599
This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population No drug interventions prevention 4 completed NCT00594958
Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51 No drug interventions prevention 3 completed NCT00776230
Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling No drug interventions prevention 3 completed NCT00595465
Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51 No drug interventions prevention 3 completed NCT03204227
Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age No drug interventions prevention 2 completed NCT00694460
Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers No drug interventions prevention 2 completed NCT01296360
Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country No drug interventions prevention 3 completed NCT00735644
Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines No drug interventions prevention 3 completed NCT01900444
Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea No drug interventions prevention 3 completed NCT01662440
Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects No drug interventions prevention 3 completed NCT01981967
Post-licensure Safety Study of IMOJEV® in Thailand No drug interventions prevention 4 completed NCT00216268
Treatment of Japanese Encephalitis No drug interventions treatment 2 unknown_status NCT01335412
Safety Surveillance After Immunization With IXIARO No drug interventions Not Available Not Available completed NCT02933710
Postmarketing Surveillance Study for IMOJEV® in Republic of Korea No drug interventions Not Available Not Available completed NCT01163123
Seroepidemiology of Japanese Encephalitis Virus Infection in Hualien, Taiwan No drug interventions Not Available Not Available unknown_status NCT01408537
Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai Children No drug interventions prevention 3 completed NCT00412516
Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine No drug interventions prevention 3 completed NCT00249769
Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine No drug interventions prevention 3 completed NCT04223037
Purified Inactivated Japanese Encephalitis Vaccine prevention 3 unknown_status